QFR® as tool for pancoronary assessment of ACS patients undergoing PCI In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist on

The non-invasive QFR-guided PCI approach is superior to the angio-guided PCI approach! Today, November 4, 2021, Mr. Xu Bo, Dept of Cardiology, Fuwai hospital, National Center for Cardiovascular Diseases, Chinese

Medis is introducing new Deep Learning contours for the Left Ventricle in the long axis. This will reduce the time needed for both the long axis function analysis, as well

QFR® as a helpful tool in daily clinical practice in Spain In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist on

QFR® in daily practice and the benefits of functional assessment In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist on his/her

QFR® as a method to reduce procedure-related ionising radiation In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist on his/her research

QFR® as a predictive tool for nontarget vessel-related events in STEMI patients In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist

As Chief Scientific Officer at Medis Medical Imaging, I have participated actively in many EuroPCR meetings over the past few years. Since the introduction of QFR at the EuroPCR in

QFR® as a predictive tool for post PCI physiology In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist on his/her research

Medis Suite MR is our solution for the assessment of the different structures of the heart and the heart’s function in both scientific research and in clinical routine. It comes

QFR® as a new tool for the assessment of non-culprit lesions in ACS In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a

QFR® identified additional lesions at risk for future nontarget vessel–related events in STEMI through 5 years of follow up. Dr Sarah Bär et al from Univ of Bern, Switzerland carried

QFR® is the innovative technology allowing for the assessment of functional significant coronary lesions, without the use of adenosine and the use of pressure wires. In addition detailed anatomical information

In a recent prospective study in 421 patients, the fluoroscopy time (FT) was measured. With QFR® the FT was only 47% of that of FFR and 30% of iFR. QFR®

QFR® as a new tool for the evaluation of CAD patients In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist on

Medis Medical imaging is celebrating the 100th published peer-reviewed manuscript on our Quantitative Flow Ratio (QFR®) solution. QFR® is the innovative technology allowing for the non-invasive assessment of functional significant

Medis is very proud to announce a collaboration for QFR® with GE Middle East: “This collaboration with Medis means that technology that was exclusively available for research centers is now

QFR® and TAVI: A promising development In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist on his/her research in cardiovascular imaging.

At Medis we believe that QFR® is the future in angiography, QFR® is a non-non-invasive angiography based physiologic assessment of the presence and extent of coronary artery disease. QFR® provides

This last week, the 1st week of February 2021, a number of interesting papers related to QFR® were published in the international literature, which I would like to describe briefly

Medis is proud to be recognized for its MR Atrial Strain solution, which was found to be at par with the Ultrasound Atrial Strain solution (AMID/Medis); this last one is regarded as the gold standard in

Leiden, The Netherlands – May 7, 2020 MEDIS MEDICAL IMAGING SYSTEMS ACQUIRES AMID AND SECURES FURTHER INVESTMENT FROM VAN HERK VENTURES MEDIS, a leading developer and supplier of software applications for image-based

The next step for non-invasive angiography in the United States and CanadaWe are proud to announce our formal distribution partnership with ACIST to co-market QFR® in the United States and Canada.

Recently Dr Simone Biscaglia and colleagues of the team of Prof Gianluca Campo published this very important paper in JACC interventions. A total of 751 vessels in 602 patients were

The ITEA project BENEFIT aimed to support clinicians in selecting the optimal diagnostic and treatment pathway for patients. As a first, a procedure called QFR® (Quantitative Flow Ratio) analysis was developed by

You might all have seen the newest Medis 1 on 1 series, in which prof. Hans Reiber, CSO Medis Medical Imaging, is interviewing researchers on their latest publications and the

You might all have seen the newest Medis 1 on 1 series, in which prof. Hans Reiber, CSO Medis Medical Imaging, is interviewing researchers on their latest publications and the